New drug cocktail targets tough colorectal cancer
Disease control
Ongoing
This Phase 2 trial tests a combination of three drugs—Tislelizumab, Fruquintinib, and Metronidazole—in 33 adults with advanced colorectal cancer that has not responded to earlier treatments. The goal is to see if this mix can slow cancer growth and improve survival. Participants …
Phase: PHASE2 • Sponsor: Jing-yuan Fang, MD, Ph. D • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC